NIH Halts Trial of Convalescent Plasma for Mild COVID-19
By Robert Preidt HealthDay Reporter WEDNESDAY, March 3, 2021 (HealthDay News) — A clinical trial evaluating the use of convalescent plasma in patients with mild to moderate COVID-19 symptoms has been halted because the treatment didn’t benefit them, according to the U.S. National Institutes of Health. Convalescent plasma (also called “survivor’s plasma”) is derived … Read more